Fierce Pharma March 8, 2024
As President Joe Biden doubles down on the price negotiation measures in the Inflation Reduction Act (IRA), prominent industry lobbying group the Pharmaceutical Research and Manufacturers of America (PhRMA) isn’t letting its legal challenge go down without a fight.
PhRMA and its allies the National Infusion Center Association (NICA) and the Global Colon Cancer Association this week appealed a recent loss in Texas federal court, taking their argument to the U.S. Court of Appeals for the Fifth Circuit, Bloomberg reports.
The move comes a few weeks after U.S. District Judge David Ezra dismissed PhRMA’s lawsuit challenging the IRA’s negotiation measures on procedural grounds.
PhRMA and its partners had argued that the government pricing negotiates tread on provisions outlined in the...
Today's Sponsors
Today's Sponsor